RESOURCES
In the past, myopia has been viewed as a minor inconvenience that could be addressed through vision correction. But over the last several decades, our understanding of myopia has changed, and it is now considered to be a progressive disease1-3 requiring early intervention to avoid sight-threatening complications later in life.4-5
RESOURCES image
JOHNSON & JOHNSON VISION IS HERE TO HELP image
JOHNSON & JOHNSON VISION IS HERE TO HELP
We’ve created this website to encourage you to adopt a new approach to myopia management in your clinical practice, with a particular emphasis on treating your pediatric patients. But we’ve gone further than that, with a robust library of resources that provides you with the most up-to-date research on myopia, tools for managing your practice, marketing materials, and more.Once you’ve signed up, our team will be in touch with you to discuss and provide more support for you on myopia management practice. You will also receive updates via email as new information, research and treatments become available.
Managing Myopia in Children into Early Adulthood: Quick Guidelines*
This one-page checklist covers basic eye-exam components, identifying children with myopia, myopia-control consultation, treatment, and monitoring.
read more
This one-page checklist covers basic eye-exam components, identifying children with myopia, myopia-control consultation, treatment, and monitoring.
read more
Managing Myopia: A Clinical Response to the Global Epidemic*
For additional education information, please click here to access Johnson & Johnson`s Managing Myopia Clinical Guide.
read more
For additional education information, please click here to access Johnson & Johnson`s Managing Myopia Clinical Guide.
read more
Why Every Myopic Child Needs to be Treated*
A brief but essential article detailing the urgency of treating child myopes by Dr. Noel Brennan, Clinical Research Fellow at Johnson & Johnson Vision and a former recipient of a Senior Fulbright Scholarship from Stanford University. This article originally appeared in the Review of Myopia Management.
read more
A brief but essential article detailing the urgency of treating child myopes by Dr. Noel Brennan, Clinical Research Fellow at Johnson & Johnson Vision and a former recipient of a Senior Fulbright Scholarship from Stanford University. This article originally appeared in the Review of Myopia Management.
read more
Efficacy in Myopia Control*
Soon to be published in Progress and Retinal Eye Research, this comprehensive article is an in-depth review and analysis of the concept of efficacy in myopia control. Funded by Johnson & Johnson Vision, it draws on accumulated information available in the scientific literature as well as our own studies to assess the efficacy of interventions to slow progression and explore resultant implications.
read more
Soon to be published in Progress and Retinal Eye Research, this comprehensive article is an in-depth review and analysis of the concept of efficacy in myopia control. Funded by Johnson & Johnson Vision, it draws on accumulated information available in the scientific literature as well as our own studies to assess the efficacy of interventions to slow progression and explore resultant implications.
read more
*Ces informations sont fournies aux cliniciens uniquement à des fins éducatives et pratiques. Chaque situation clinique doit être considérée comme unique à chaque patient, et tous les traitements personnalisés en conséquence. Soins de la vision Johnson & Johnson, division de Johnson & Johnson inc. n'approuve ni ne recommande toute technique particulière.
REFERENCES
1. Flitcroft DI. The complex interactions of retinal, optical and environmental factors in myopia aetiology. Prog Retin Eye Res. 2012;31(6):622-660.
2. Donovan L, Sankaridurg P, Ho A et coll Myopia progression rates in urban children wearing single-vision spectacles. OVS 2012;89(1):27-32.
3. Pärssinen O, Kauppinen M. Risk factors for high myopia: a 22-year follow-up study from childhood to adulthood. Acta Ophthalmologica. 2019;97(5):510-518.
4. Flitcroft DI. The complex interactions of retinal, optical and environmental factors in myopia aetiology. Prog Retin Eye Res. 2012;31(6):622-660.
5. Haarman AEG, Enthoven CA, Willem Tideman JL, Tedja MS, Verhoeven VJM, Klaver CCW. The complications of myopia: A review and meta-analysis. Investigative Ophthalmology and Visual Science. 2020;61(4):49-49.
PP2021ABLM4065
2. Donovan L, Sankaridurg P, Ho A et coll Myopia progression rates in urban children wearing single-vision spectacles. OVS 2012;89(1):27-32.
3. Pärssinen O, Kauppinen M. Risk factors for high myopia: a 22-year follow-up study from childhood to adulthood. Acta Ophthalmologica. 2019;97(5):510-518.
4. Flitcroft DI. The complex interactions of retinal, optical and environmental factors in myopia aetiology. Prog Retin Eye Res. 2012;31(6):622-660.
5. Haarman AEG, Enthoven CA, Willem Tideman JL, Tedja MS, Verhoeven VJM, Klaver CCW. The complications of myopia: A review and meta-analysis. Investigative Ophthalmology and Visual Science. 2020;61(4):49-49.
REFERENCES
